CN103450346A - 一种依替巴肽的液相合成方法 - Google Patents
一种依替巴肽的液相合成方法 Download PDFInfo
- Publication number
- CN103450346A CN103450346A CN2013103901062A CN201310390106A CN103450346A CN 103450346 A CN103450346 A CN 103450346A CN 2013103901062 A CN2013103901062 A CN 2013103901062A CN 201310390106 A CN201310390106 A CN 201310390106A CN 103450346 A CN103450346 A CN 103450346A
- Authority
- CN
- China
- Prior art keywords
- trt
- cys
- pro
- lys
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310390106.2A CN103450346B (zh) | 2012-09-14 | 2013-08-30 | 一种依替巴肽的液相合成方法 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012103396425 | 2012-09-14 | ||
CN201210339642.5 | 2012-09-14 | ||
CN2012103396425A CN102924569A (zh) | 2012-09-14 | 2012-09-14 | 一种依替巴肽的液相合成方法 |
CN201310390106.2A CN103450346B (zh) | 2012-09-14 | 2013-08-30 | 一种依替巴肽的液相合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103450346A true CN103450346A (zh) | 2013-12-18 |
CN103450346B CN103450346B (zh) | 2015-06-24 |
Family
ID=47639518
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012103396425A Pending CN102924569A (zh) | 2012-09-14 | 2012-09-14 | 一种依替巴肽的液相合成方法 |
CN201310390106.2A Active CN103450346B (zh) | 2012-09-14 | 2013-08-30 | 一种依替巴肽的液相合成方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012103396425A Pending CN102924569A (zh) | 2012-09-14 | 2012-09-14 | 一种依替巴肽的液相合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN102924569A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106366177A (zh) * | 2016-09-07 | 2017-02-01 | 烟台海安药物研发有限公司 | 一种胸腺五肽甲酯偶合物及其制备方法 |
CN106459150A (zh) * | 2014-06-26 | 2017-02-22 | 丸石制药株式会社 | 合成五肽的制造方法 |
CN106916219A (zh) * | 2017-04-10 | 2017-07-04 | 上海化工研究院有限公司 | 一种稳定同位素标记α‑乳白蛋白特征肽段的合成方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101993475A (zh) * | 2009-08-21 | 2011-03-30 | 杭州诺泰制药技术有限公司 | 一种全液相依替巴肽(Eptifibatide)的合成方法 |
CN102040652A (zh) * | 2009-10-12 | 2011-05-04 | 杭州诺泰制药技术有限公司 | 一种固液相结合依替巴肽(Eptifibatide)的合成方法 |
US20110118437A1 (en) * | 2004-06-14 | 2011-05-19 | Divya Lal Saksena | Process for the Synthesis of Cyclic Heptapeptide |
-
2012
- 2012-09-14 CN CN2012103396425A patent/CN102924569A/zh active Pending
-
2013
- 2013-08-30 CN CN201310390106.2A patent/CN103450346B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110118437A1 (en) * | 2004-06-14 | 2011-05-19 | Divya Lal Saksena | Process for the Synthesis of Cyclic Heptapeptide |
CN101993475A (zh) * | 2009-08-21 | 2011-03-30 | 杭州诺泰制药技术有限公司 | 一种全液相依替巴肽(Eptifibatide)的合成方法 |
CN102040652A (zh) * | 2009-10-12 | 2011-05-04 | 杭州诺泰制药技术有限公司 | 一种固液相结合依替巴肽(Eptifibatide)的合成方法 |
Non-Patent Citations (1)
Title |
---|
张琦: "血小板糖蛋白Ilb/11Ia受体拮抗剂依替巴肽的合成研究", 《CNKI中国知网数据库》, 10 May 2010 (2010-05-10) * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106459150A (zh) * | 2014-06-26 | 2017-02-22 | 丸石制药株式会社 | 合成五肽的制造方法 |
CN106459150B (zh) * | 2014-06-26 | 2020-01-24 | 丸石制药株式会社 | 合成五肽的制造方法 |
CN106366177A (zh) * | 2016-09-07 | 2017-02-01 | 烟台海安药物研发有限公司 | 一种胸腺五肽甲酯偶合物及其制备方法 |
CN106916219A (zh) * | 2017-04-10 | 2017-07-04 | 上海化工研究院有限公司 | 一种稳定同位素标记α‑乳白蛋白特征肽段的合成方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103450346B (zh) | 2015-06-24 |
CN102924569A (zh) | 2013-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103242431B (zh) | 一种比伐卢定的制备方法 | |
CN101759777B (zh) | 一种戈舍瑞林的合成方法 | |
CN103374054A (zh) | 一步法固相合成多肽的方法 | |
CN102702320B (zh) | 一种制备爱啡肽的方法 | |
CN103450346B (zh) | 一种依替巴肽的液相合成方法 | |
CN103180335A (zh) | 用于制备地加瑞克及其中间体的方法 | |
CN101735308A (zh) | 一种布舍瑞林的合成方法 | |
CN101104638B (zh) | 胸腺素α1的固相合成工艺 | |
TWI247012B (en) | Process for rapid solution synthesis of peptides | |
CN101747412A (zh) | 一种依替非巴肽的合成制备工艺 | |
CN105777871A (zh) | 一种环五肽的合成方法 | |
CN106478805A (zh) | 一种glp-1衍生物的制备方法 | |
CN101857629A (zh) | 布雷默浪丹的固相合成方法 | |
CN103665115B (zh) | 环十肽化合物gg-110824的化学制备方法 | |
CN105037496B (zh) | 一种依替巴肽的制备方法 | |
CN103665109B (zh) | 成骨生长肽碳端五肽的合成方法 | |
CN103539832B (zh) | 一种硼替佐米工艺的改进方法 | |
CN103172704A (zh) | 一种抗肿瘤小肽FpAT的制备方法 | |
CN111285921B (zh) | Bdk辅助基团及基于bdk辅助基团的普卡那肽及类似物的液相全合成方法 | |
Yamada et al. | Solid-state 17O NMR in Biological Solids: Efficient 17O Labeling of Amino Acids and Peptides | |
CN102174081B (zh) | 埃替非巴肽及其前体的制备方法 | |
CN101255187B (zh) | Atl肽的固相合成方法 | |
CN104558159B (zh) | 比伐芦定中间体的固相合成方法 | |
CN113292508B (zh) | 一类含天冬酰胺或谷氨酰胺的环二肽的合成方法 | |
CN102827249A (zh) | 一种依替巴肽的液相合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: 264006 room B, building, No. 3, No. 32, Pioneer Park, Zhujianglu Road, Shandong, Yantai, China Applicant after: Hai'an, Yantai medicament research and development company limited Address before: 264006 room B, building, No. 3, No. 32, Pioneer Park, Zhujianglu Road, Shandong, Yantai, China Applicant before: Yantai High Polypeptide Pharmaceutical Research & Development Co., Ltd. |
|
CB03 | Change of inventor or designer information |
Inventor after: Gao Xiuyan Inventor after: Wang Xidi Inventor after: Xu Wenjuan Inventor after: Ren Xiaomin Inventor after: Jiang Guosheng Inventor before: Gao Xiuwei Inventor before: Gao Xiuyan Inventor before: Ren Xiaomin Inventor before: Wang Pu |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: GAO XIUWEI GAO XIUYAN REN XIAOMIN WANG PU TO: GAO XIUYAN WANG XIDI XU WENJUAN REN XIAOMIN JIANG GUOSHENG Free format text: CORRECT: APPLICANT; FROM: YANTAI HIGH ACTIVE PEPTIDE DRUGS RESEARCH + DEVELOPMENT TECHNOLOGY CO., LTD. TO: YANTAI HIGH ACTIVE DRUGS RESEARCH + DEVELOPMENT CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 264006 Yantai Development Zone, Zhujianglu Road, No. 32, the park, the international students in the park Patentee after: Shandong Bio Technology Co., Ltd. Address before: 264006 room B, building, No. 3, No. 32, Pioneer Park, Zhujianglu Road, Shandong, Yantai, China Patentee before: Hai'an, Yantai medicament research and development company limited |